Concerning the management of VEGF inhibitors-induced hypertension, there are few case-reports of the efficacy of long-acting NO donor drugs in two patients who were treated with antiangiogenic cancer therapies and were resistant to conventional antihypertensive drugs [90]. The gene discussed is VEGFA; the disease is Hypertension.